Phenotypic and Genotypic Detection of Carbapenem Resistance in Urinary Enterobacterales Isolates: A Prospective Cross-Sectional Diagnostic Evaluation Study

  16 April 2026

This study highlights the growing prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in urinary tract infections, driven mainly by carbapenemase enzymes such as NDM and OXA-48-like, particularly in Escherichia coli and Klebsiella pneumoniae. Among 350 isolates, 110 were confirmed as carbapenem-resistant by PCR, underscoring significant resistance levels. While the Carba-NP test showed high specificity, its lower sensitivity compared to multiplex PCR indicates that molecular diagnostics are essential for accurate detection. The findings stress the urgent need for rapid identification, targeted therapy, and strengthened antimicrobial stewardship and infection control to limit the spread of these highly resistant pathogens.

Further reading: Cureus
Author(s): Pooja P et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!